XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Income Statement - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
 [1]
Profit or loss [abstract]      
Revenue $ 59,768 $ 59,380 $ 57,786
Cost of sales (26,744) (27,396) (26,305)
Gross profit 33,024 31,984 31,481
Distribution expenses (6,201) (6,277) (6,389)
Sales and marketing expenses (7,156) (7,158) (6,752)
Administrative expenses (4,983) (4,738) (4,414)
Other operating income/(expenses) 779 778 841
Exceptional costs above profit from operations 25 (624) (251)
Profit from operations 15,487 13,966 14,517
Finance expense (6,376) (6,133) (5,814) [2]
Finance income 1,024 1,031 1,665 [2]
Net finance income/(expense) (5,353) (5,102) (4,148) [2]
Share of results of associates 329 295 299
Exceptional share of results of associates 104 (35) (1,143)
Profit before tax 10,568 9,124 9,524
Income tax expense (3,152) (2,234) (1,928)
Profit of the period 7,416 6,891 7,597
Profit of the period attributable to:      
Equity holders of AB InBev 5,855 5,341 5,969
Non-controlling interest $ 1,561 $ 1,550 $ 1,628
Basic earnings per share $ 2.92 $ 2.65 $ 2.97
Diluted earnings per share $ 2.86 $ 2.6 $ 2.91
[1] As from 1 January 2023, mark-to-market gains/(losses) on derivatives related to the hedging of the share-based payment programs are reported in the exceptional net finance income/(expense). The 2022 presentation were amended to conform to the 2023 and 2024 presentation.
[2] As from 1 January 2023, mark-to-market gains/(losses) on derivatives related to the hedging of the share-based payment programs are reported in the exceptional net finance income/(expense). The 2022 presentation was amended to conform to the 2023 and 2024 presentation.